Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

3.7K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
3.7K
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

24
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features...
24
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

35
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the...
35
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

3.7K
Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
3.7K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

691
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
691
Hormones of the Adrenal Glands01:31

Hormones of the Adrenal Glands

5.9K
Adrenal hormones play a pivotal role in maintaining the body's electrolyte balance and orchestrating responses to stress, showcasing the intricate functions of the adrenal cortex and medulla.
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and...
5.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-Glucocorticoid Immunosuppressive Therapy in Post-Glucocorticoid Persistent or Recurrent Primary Autoimmune Hypophysitis: A Systematic Review.

Clinical endocrinology·2026
Same author

Diagnostic Performance of Parathyroid CT and CT-Guided Targeted Parathyroidectomy in MEN1-Associated Primary Hyperparathyroidism.

Annales d'endocrinologie·2026
Same author

Triple-tracer Functional Imaging in a Rare Case of Thyroid Paraganglioma.

Clinical nuclear medicine·2026
Same author

Contemporary management of adrenocortical carcinoma: A narrative review.

Urologic oncology·2026
Same author

Diagnostic and Management Challenges in Pheochromocytoma and Paraganglioma: A Clinical Review.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2026
Same author

3β-Hydroxysteroid dehydrogenase type-2 deficiency: Our experience and gonadal function-focused systematic review.

Endocrine·2026

Related Experiment Video

Updated: Apr 28, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

9.1K

Management issues with exogenous steroid therapy.

Hiren Patt1, Tushar Bandgar1, Anurag Lila1

  • 1Department of Endocrinology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.

Indian Journal of Endocrinology and Metabolism
|June 10, 2014
PubMed
Summary

Glucocorticoids (GCs) are vital for inflammatory conditions but pose risks. This study reviews GC monitoring and managing their serious side effects, emphasizing risk-benefit assessment for patient safety.

Keywords:
Adrenal suppressionavascular necrosisexogenous cushing's syndromeglucocorticoids-induced osteoporosis

More Related Videos

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K
Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
05:55

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

1.1K

Related Experiment Videos

Last Updated: Apr 28, 2026

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
08:02

Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids

Published on: April 25, 2016

9.1K
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
08:20

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome

Published on: October 2, 2018

11.2K
Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
05:55

Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head

Published on: September 27, 2024

1.1K

Area of Science:

  • Pharmacology and Therapeutics
  • Endocrinology
  • Immunology

Background:

  • Glucocorticoids (GCs) are widely prescribed for inflammatory and autoimmune diseases.
  • Despite therapeutic benefits, long-term GC use is associated with significant systemic side effects.
  • GC formulations include oral, topical, and inhaled routes, all capable of causing adverse events.

Purpose of the Study:

  • To outline strategies for monitoring patients undergoing glucocorticoid therapy.
  • To discuss the management of complications arising from glucocorticoid use.
  • To highlight the importance of careful risk-benefit analysis before initiating steroid treatment.

Main Methods:

  • Literature review on glucocorticoid pharmacology and clinical applications.
  • Analysis of reported side effects and complications associated with GC therapy.
  • Synthesis of current guidelines for patient monitoring and adverse event management.

Main Results:

  • GCs can induce a spectrum of side effects, from minor weight gain to life-threatening conditions like adrenal suppression and sepsis.
  • Systemic adverse effects are common across all GC administration routes.
  • Effective patient monitoring and prompt management are crucial for mitigating GC-related morbidity.

Conclusions:

  • The decision to use glucocorticoids necessitates a thorough evaluation of individual patient risks versus benefits.
  • Comprehensive monitoring protocols are essential for early detection of GC-induced complications.
  • Proactive management strategies are key to ensuring patient safety during long-term glucocorticoid therapy.